Czechia, Oct. 29 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Institut klinicke a experimentalni mediciny for Immunoglobulins - Imunoglubuliny SCIG VI - HYQVIA. The value of the contract is worth 6723750 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....